PlainMeds provides educational information only. This is not medical advice. Always consult your doctor or pharmacist.

azilsartan

Verify with FDA → · CMS NADAC pricing →

Brand names: Edarbi

Angiotensin II Receptor Blocker (ARB) Rx

Edarbyclor is a drug that combines two medicines to lower high blood pressure. It helps reduce the risk of strokes and heart attacks.

Drug Pricing (NADAC)

Brand Price

$7.61/unit

Generic Available

No

AZURITY

Pricing data from NADAC (CMS), effective December 18, 2024. Compare all drug costs →

What it does

Edarbyclor is used to treat high blood pressure.

Common side effects

Dizziness, Fatigue

Key warnings

Edarbyclor can harm your unborn baby.

How It Works

Edarbyclor contains two medicines that work in different ways to lower blood pressure. One medicine blocks a substance that tightens blood vessels. The other medicine helps your body get rid of extra salt and water.

How to Take It

Take Edarbyclor once a day. You can take it with or without food. The starting dose is usually one 40/12.5 mg tablet daily. Your doctor may increase the dose to 40/25 mg after 2 to 4 weeks if needed.

Pregnancy & Breastfeeding

Edarbyclor can cause harm to an unborn baby, including injury or death. Do not take this medicine if you are pregnant or plan to become pregnant. It is not recommended to breastfeed while taking Edarbyclor.

Missed Dose

If you miss a dose, take it as soon as you remember. If it is close to your next dose, skip the missed dose and continue with your regular schedule.

Storage

Store Edarbyclor in its original container at room temperature (59°-86°F). Keep the container tightly closed and protect from moisture and light.

Serious Warnings

Edarbyclor can harm your unborn baby. If you are pregnant or become pregnant, stop taking this medicine and tell your doctor right away.

Known Drug Interactions

7.2 Dual Blockade of the Renin-Angiotensin System (RAS) Dual blockade of the RAS with angiotensin receptor blockers, ACE inhibitors, or aliskiren is associated with increased risks of hypotension, hyperkalemia, and changes in renal function (including acute renal failure) compared to monotherapy. Do not coadminister aliskiren with Edarbyclor in patients with diabetes. Avoid use of aliskiren with Edarbyclor in patients with renal impairment (GFR <60 mL/min).

Mechanism: Both drugs block the same system that controls blood pressure, which can cause your blood pressure to drop too low and strain your kidneys. This can also lead to dangerously high potassium levels in your blood.

What to do: Do not take these together if you have diabetes or kidney problems. Your doctor will likely prescribe only one of these to protect your health.

7 DRUG INTERACTIONS Renal clearance of lithium is reduced by diuretics, such as chlorthalidone increasing the risk of lithium toxicity ( 7 ) NSAIDS increase risk of renal dysfunction and interfere with antihypertensive effect ( 7 ) Dual inhibition of the renin-angiotensin system: Increased risk of renal impairment, hypotension, and hyperkalemia ( 7 ) Lithium: Increases in serum lithium concentrations and lithium toxicity ( 7 ) 7.1 Non-Steroidal Anti-Inflammatory Agents including Selective Cyclooxygenase-2 Inhibitors (COX-2 Inhibitors) In patients who are elderly, volume-depleted (including ...

Mechanism: These drugs work in different ways to lower blood pressure, which can increase the risk of very low blood pressure and kidney problems.

What to do: Your doctor should monitor your blood pressure and kidney function closely while you are taking these medications.

moderate lithium

7 DRUG INTERACTIONS Renal clearance of lithium is reduced by diuretics, such as chlorthalidone increasing the risk of lithium toxicity ( 7 ) NSAIDS increase risk of renal dysfunction and interfere with antihypertensive effect ( 7 ) Dual inhibition of the renin-angiotensin system: Increased risk of renal impairment, hypotension, and hyperkalemia ( 7 ) Lithium: Increases in serum lithium concentrations and lithium toxicity ( 7 ) 7.1 Non-Steroidal Anti-Inflammatory Agents including Selective Cyclooxygenase-2 Inhibitors (COX-2 Inhibitors) In patients who are elderly, volume-depleted (including ...

Mechanism: Azilsartan can make it harder for the kidneys to remove lithium from the body. This causes lithium levels to build up, which can lead to dangerous side effects.

What to do: Your doctor should monitor your lithium blood levels closely. They may need to adjust your lithium dose while you are taking this medication.

Common Questions

What should I do if I feel dizzy after taking Edarbyclor?
Lie down until the dizziness passes. Talk to your doctor if dizziness continues.
Can I take Edarbyclor with other blood pressure medicines?
Yes, Edarbyclor can be taken with other blood pressure medicines, but your doctor will decide if this is right for you.
Can I drink alcohol while taking Edarbyclor?
Talk to your doctor about drinking alcohol while taking Edarbyclor. Alcohol can lower your blood pressure and may increase the risk of side effects.
What if I have kidney problems?
Tell your doctor if you have kidney problems. Your doctor may need to monitor your kidney function while you are taking Edarbyclor.
Can Edarbyclor affect my potassium levels?
Yes, Edarbyclor can affect your potassium levels. Your doctor may check your potassium levels periodically.
Is it okay to take NSAIDs like ibuprofen with Edarbyclor?
Taking NSAIDs (like ibuprofen) with Edarbyclor can increase the risk of kidney problems. Talk to your doctor before taking NSAIDs.
What if I am taking lithium?
Taking Edarbyclor with lithium can increase lithium levels in your blood. Your doctor will monitor your lithium levels closely.
Are there any foods I should avoid?
You should limit your sodium (salt) intake while taking Edarbyclor.
What does Edarbyclor look like?
Edarbyclor tablets are round, pale red (40/12.5 mg) or light red (40/25 mg), and have markings on them.
Who should not take Edarbyclor?
You should not take Edarbyclor if you cannot urinate or if you have diabetes and are taking a medicine that contains aliskiren.
What are the common side effects of azilsartan?
The most commonly reported side effects of azilsartan include Dizziness, Fatigue. Always consult your healthcare provider about potential side effects.
Does azilsartan interact with other medications?
Yes, azilsartan has 3 known drug interactions. Notable interactions include aliskiren, chlorthalidone, lithium. Always inform your doctor about all medications you are taking.
What drug class is azilsartan?
azilsartan belongs to the Angiotensin II Receptor Blocker (ARB) drug class. It requires a prescription (Rx). Edarbyclor is used to treat high blood pressure.
Is azilsartan safe during pregnancy?
Edarbyclor can cause harm to an unborn baby, including injury or death. Do not take this medicine if you are pregnant or plan to become pregnant. Always consult your healthcare provider before using any medication during pregnancy or breastfeeding.

Related Medications in Angiotensin II Receptor Blocker (ARB)

Other drugs grouped near azilsartan — same-class peers and common alternatives.

Compare azilsartan vs acebutolol side-by-side →

Medication Guides

Related Health & Safety Data

Save on azilsartan

Compare prices and find discounts at pharmacies near you. Free coupons can save up to 80% on prescriptions.

Disclosure: This link may earn us a commission at no extra cost to you. See our terms.

What the FDA Data Shows for azilsartan

The FDA label for azilsartan (sold under brand names such as Edarbi) classifies it as a prescription-only medication in the Angiotensin II Receptor Blocker (ARB) class. Edarbyclor is used to treat high blood pressure. Official labeling lists 2 commonly reported side effects, including Dizziness, Fatigue.

Post-market surveillance from the FDA Adverse Event Reporting System (FAERS) captures real-world experience. Voluntary reports accumulate over the lifetime of a drug and reflect wide-ranging clinical use. The database also lists 3 documented drug interactions derived from FDA labeling, with the top-flagged interaction rated major severity. NADAC pricing from CMS.

Report counts do not establish causation — a FAERS entry documents a temporal association, not proof that the drug produced the outcome. Widely prescribed medications naturally accumulate more reports than niche therapies, so raw totals must be interpreted alongside total exposure. Shortage status, recall history, and patent information further shape supply and switching decisions. This page summarizes public FDA data for educational purposes only and is not a substitute for professional medical advice — always consult a licensed healthcare provider before starting, stopping, or changing any medication.

Data Sources

Drug labeling: FDA Drug Labels (SPL/DailyMed). Adverse events: FDA Adverse Event Reporting System (FAERS). Pricing: CMS National Average Drug Acquisition Cost (NADAC).

FAERS reports are voluntary and do not establish causation. Drug interactions are derived from FDA labeling and clinical references. Always consult a healthcare professional before making medication decisions.

Last updated: July 23, 2025

All federal data sources used on this page